Next |
home / stock / torc / torc message board
Subject | By | Source | When |
---|---|---|---|
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 03/28/2021 2:12:59 AM |
$torc $5 with news | Taurus69 | investorshub | 02/25/2021 10:06:46 PM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 02/25/2021 10:05:48 PM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 02/06/2021 11:26:43 PM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 01/17/2021 4:51:26 AM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 12/20/2020 12:11:17 AM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 11/23/2020 9:52:27 PM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 11/10/2020 10:03:46 PM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 10/31/2020 1:26:32 AM |
$torc $2.28 ? 0.0 (0.00%) | Taurus69 | investorshub | 10/03/2020 6:16:52 PM |
$torc $5 with news | Taurus69 | investorshub | 09/05/2020 6:47:51 AM |
$torc $2.06 v -0.02 (-0.96%) | Taurus69 | investorshub | 09/05/2020 6:47:00 AM |
$torc $2.49 v -0.23 (-8.46%) | Taurus69 | investorshub | 08/01/2020 6:55:00 PM |
Never fails with $TORC. They pr and price | andre1234 | investorshub | 07/29/2020 12:51:43 AM |
New base established. Anything below 2.60 is a | andre1234 | investorshub | 07/21/2020 2:12:38 AM |
$torc $2.99 ^ 0.5 (20.08%) | Taurus69 | investorshub | 07/19/2020 5:26:28 PM |
All smiles! Patience pay$! | andre1234 | investorshub | 07/19/2020 4:20:37 AM |
Appears weve reached a new level of support. | andre1234 | investorshub | 07/12/2020 12:35:04 AM |
Patience.... | andre1234 | investorshub | 06/23/2020 12:56:27 AM |
Will be trading above $4 once we get | andre1234 | investorshub | 06/18/2020 12:53:15 AM |
News, Short Squeeze, Breakout and More Instantly...
- Adicet Emerges as a Leading Allogeneic Gamma Delta T Cell Therapy Company Focused on Oncology - -Trading to Commence on September 16, 2020 on The Nasdaq Global Market Under Ticker Symbol “ACET”- MENLO PARK, Calif. and BOSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) -...
MENLO PARK, Calif. , Aug. 5, 2020 /PRNewswire/ -- Adicet Bio, Inc., a privately-held biopharmaceutical company, today announced that it has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals, in accordance with the t...
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today provided a corporate update and reported financial results ...